The diet, which was introduced to patients with type 2 diabetes, was shown to improve glycemic control
Macrogol is an osmotic laxative that draws water into the bowel to soften stools and is recommended by NICE as first-line treatment for chronic constipation in adults Constipation affects 1-10% of Ozempic users and over 10% of Wegovy users, caused by semaglutide's effect on gastrointestinal motility Bulk-forming laxatives like ispaghula husk may suit mild constipation but require adequate fluid intake to prevent obstruction Stimulant laxatives such as senna or bisacodyl provide short-term relief for severe constipation and should be used under medical supervision No specific laxative interactions with Ozempic are documented, but patients should inform healthcare providers of all medications taken Persistent or severe constipation, abdominal pain, vomiting, or inability to pass stool requires urgent medical assessment Not sure where to start
For Ozempic, patients should remove the needle after each injection and replace the pen cap to protect the medication from light exposure
Animal studies have shown that semaglutide may cause congenital disabilities, low birth weight and increased risk of miscarriage, although these effects have not been thoroughly studied in humans
Common effects include nausea, diarrhoea, vomiting, abdominal pain, constipation and decreased appetite, especially during dose increases